We’re excited to announce a new partnership with CAST, combining deep software analysis and technical evaluation expertise to offer comprehensive software solutions and services.
Illinois’ BIPA is a model for upcoming biometric legislation; we expect 20% of states will have biometric privacy laws by 2024.
The most recent Health IT vendor to settle with the government is a direct result of the DOJ’s new Civil Cyber-Fraud Initiative.
We use SAST tools during our tech due diligence engagements to provide independent analysis of security risk and to help provide recommendations.
Quandary Peak’s review of FDA’s final guidance leads us to believe we could see meaningful expansion of the amount of CDSS qualifying as a medical device, which could subject many current and future CDS software applications to FDA oversight.
Technical due diligence is the process to better evaluate software and identify its strengths and weaknesses. TDD is a critical step in any software-centric transaction.
A standard approach for representing patient addresses across all health IT systems was needed to improve patient matching using accurate address information. Enter Project US@, the “Unified Specification for Address in Health Care.”
As medical devices evolve to better treat and monitor patient health, cybersecurity remains a top priority. As per FDA guidance, “medical device security is a shared responsibility…”
Recent advances and increased application of computer-aided decision making, including artificial intelligence (AI) and machine learning (ML), have caught the attention of consumer protection organizations and regulatory agencies.
The FDA first drafted guidance on CDS software in 2017, but finalizing it has not been a priority for the agency since. That’s set to change next year.
